Skip to main content
SpringerLink
Log in

Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran

  • Research Article
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Objective Adverse Drug Reactions (ADRs) are a major cause of patient morbidity and mortality. Spontaneous reporting of ADRs remains the cornerstone of pharmacovigilance and is important in maintaining patient safety. In order to determine whether our pharmacovigilance system could be improved, and identify reasons for under-reporting, a study to investigate the role of pharmacists in ADR reporting was performed in Shiraz. Setting: The pharmacies in Shiraz, capital of Fars province in Iran. Methods A questionnaire was prepared to investigate knowledge and attitude of pharmacists regarding ADR reporting. The questionnaire was given to 200 pharmacists who participated in a pharmacist association meeting. Main outcomes measured: The knowledge of pharmacovigilance practice, reasons for not reporting ADR, and perceptions of the Iranian pharmacists on pharmacovigilance practice were evaluated Results The response rate was 55% (n = 110). 29% of the respondents were not aware of the Iranian Pharmacovigilance Center. More than half of those responding felt that ADR reporting should be voluntary, while 26% felt it was a professional obligation. As for the purposes of ADR reporting scheme, 60% of the pharmacists falsely believed that monitoring ADR spontaneous reports aims at measuring the incidence of ADR. 42% of the pharmacists indicated that they have suspected an ADR without reporting it. Doubt about causality was the major reason for not reporting an ADR. Although our ADR center states that all suspected reactions to any drug on the market must be reported, only 17% of the respondents seemed to be aware of this responsibility. Conclusion Our pharmacists have little knowledge regarding the operation, purposes, and usefulness of ADR spontaneous reporting system. However, education and training will be important in maintaining and increasing ADR reports from pharmacists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. BMJ. 1998;316:1295–8.

    PubMed  CAS  Google Scholar 

  2. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277(4):301–6. doi:10.1001/jama.277.4.301.

    Article  PubMed  CAS  Google Scholar 

  3. Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring-Cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997;6(3):S71–7. doi:10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9.

    Article  PubMed  Google Scholar 

  4. Lazarou J, Pomeranz BH, Corey PH. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5. doi:10.1001/jama.279.15.1200.

    Article  PubMed  CAS  Google Scholar 

  5. Johnson JA, Bootman JL. Drug-related morbidity and mortality. a cost-of-illness model. Arch Intern Med. 1995;155:1949–56. doi:10.1001/archinte.155.18.1949.

    Article  PubMed  CAS  Google Scholar 

  6. Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In: Strom BL, editor. Pharmacoepidemiology. Chichester: John Wiley & Sons Ltd; 1994. p. 139–55.

    Google Scholar 

  7. Ramezani Tehrani B, Javid Nikoo N. Report of the Iranian Pharmacovigilance Center. Razi J. 2007;12:85–90. Article in Persian.

    Google Scholar 

  8. Roberts PI, Wolfson DJ, Booth TG. The role of pharmacists in adverse drug reaction reporting. Drug Saf. 1994;11(1):7–11. doi:10.2165/00002018-199411010-00002.

    Article  PubMed  CAS  Google Scholar 

  9. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BHC. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48:623–7. doi:10.1046/j.1365-2125.1999.00060.x.

    Article  PubMed  CAS  Google Scholar 

  10. Bateman DN, Sanders GLS, Rawling MD. Attitudes to adverse drug reaction reporting in the northern region. Br J Clin Pharmacol. 1992;34:421–6.

    PubMed  CAS  Google Scholar 

  11. Belton K. The European Pharmacovigilance Research Group. attitude survey of adverse drug reaction reporting by healthcare professionals across the European Union. Eur J Clin Pharmacol. 1997;52:423–7. doi:10.1007/s002280050314.

    Article  PubMed  CAS  Google Scholar 

  12. Green CF, Mottram DR, et al. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51:81–6. doi:10.1046/j.1365-2125.2001.01306.x.

    Article  PubMed  CAS  Google Scholar 

  13. Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reactions reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.

    PubMed  CAS  Google Scholar 

  14. Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23(2):165–72. doi:10.2165/00002018-200023020-00006.

    Article  PubMed  CAS  Google Scholar 

  15. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.

    PubMed  CAS  Google Scholar 

  16. Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reactions reporting: a case control study in Portugal. Drug Saf. 2006;29(4):331–40. doi:10.2165/00002018-200629040-00004.

    Article  PubMed  Google Scholar 

  17. Zerrin Toklu H, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62. doi:10.1007/s11096-008-9209-4.

    Article  Google Scholar 

  18. Granas AG, Buajordet M, Stenberg-Nilsen H, et al. Pharmacists’ attitudes toward the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16:429–34. doi:10.1002/pds.1298.

    Article  PubMed  Google Scholar 

  19. Hasford J, Goettler K, et al. Physician’s knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55:945–50. doi:10.1016/S0895-4356(02)00450-X.

    Article  PubMed  CAS  Google Scholar 

  20. Walker SR, Lumley CE. The attitudes of general practitioners to the monitoring and reporting of adverse drug reactions. Pharm Med. 1986;1:195–203.

    Google Scholar 

  21. Lumley CE, Walker SR, Hall GC, Staunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharm Med. 1986;1:205–12.

    Google Scholar 

  22. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood S. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223–6.

    PubMed  CAS  Google Scholar 

  23. Cosentino M, Leoni O, et al. Attitudes to adverse drug reaction reporting by medical practitioners in a northern Italian district. Pharmacol Res. 1997;35(2):85–8. doi:10.1006/phrs.1996.0138.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The authors thank Dr. Hashem Montaseri, Vice Chancellor for Food and Drug Organization, Shiraz University of Medical Sciences, for his support.

Funding

None

Conflict of interest

None

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

    Ghazal Vessal, Zeinab Mardani & Mehri Mollai

Authors
  1. Ghazal Vessal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeinab Mardani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehri Mollai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ghazal Vessal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vessal, G., Mardani, Z. & Mollai, M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci 31, 183–187 (2009). https://doi.org/10.1007/s11096-008-9276-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-008-9276-6

Keywords

Search

Navigation